Zealand Pharma gets EU recommendation for short bowel syndrome drug
Zealand Pharma A/S (Nasdaq: ZEAL) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)